Related Articles
Expression pattern of p‑Smad2/Smad4 as a predictor of survival in invasive breast ductal carcinoma
Aberrant promoter methylation of PCDH10 as a potential diagnostic and prognostic biomarker for patients with breast cancer
High EGFR mRNA expression is a prognostic factor for reduced survival in pancreatic cancer after gemcitabine-based adjuvant chemotherapy
Claudin 18.2: An attractive marker in pancreatic ductal adenocarcinoma
miR-19a correlates with poor prognosis of clear cell renal cell carcinoma patients via promoting cell proliferation and suppressing PTEN/SMAD4 expression